Prescribing differences in family practice for diabetic patients in Germany according to statutory or private health insurance: the case of DPP-4-inhibitors and GLP-1-agonists
The objective of this study was to analyze prescription decisions for family practice (FP) patients with Diabetes mellitus type 2 (DM2) using the case of the incretin mimetics Dipeptidyl peptidase-4 (DDP-4) in...
Source: BMC Family Practice - Category: Primary Care Authors: Gunter Laux, Sarah Berger, Joachim Szecsenyi, Petra Kaufmann-Kolle and R üdiger Leutgeb Source Type: research
More News: Primary Care